Randall B. Brenner, Chief Development & Regulatory at Paratek Pharmaceuticals, Inc. (PRTK), sold 29,282 shares at $1.96 ($58K) on 2022-12-13, disclosed to the SEC on 2022-12-14.
Scheduled sale ($58k) by Chief Development & Regulatory under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.98 | 11,105 | $22K | 38.2% |
| 2 | $1.96 | 18,177 | $36K | 61.8% |
| Total | $1.97 avg | 29,282 | $58K | 100% |
| Filing → |
| PRTK | SELL | 2022-11-01 | $12K | — | Filing → |
| PRTK | SELL | 2022-08-10 | $104K | — | Filing → |
| PRTK | SELL | 2021-12-15 | $188K | — | Filing → |